OpenURL Connection Search

Select item for more details and to access through your institution.

Immune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variant.
Published in:
Virchows Archiv: European Journal of Pathology, 2023, v. 482, n. 6, p. 1011, doi. 10.1007/s00428-023-03520-x
By:
- El Hussein, Siba;
- Medeiros, L. Jeffrey;
- Gruschkus, Stephen K.;
- Wei, Peng;
- Schlette, Ellen;
- Fang, Hong;
- Jelloul, Fatima Zahra;
- Wang, Wei;
- Fiskus, Warren;
- Kanagal-Shamanna, Rashmi;
- Loghavi, Sanam;
- Yang, Hong;
- Li, Shaoying;
- Xu, Jie;
- Tang, Zhenya;
- Thakral, Beenu;
- Jain, Nitin;
- Wierda, William G.;
- Patel, Keyur;
- Bhalla, Kapil N.
Publication type:
Article
1719. Incidence and Characterization of Invasive Fungal Infections (IFIs) in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib (IBR).
Published in:
Open Forum Infectious Diseases, 2019, v. 6, p. S630, doi. 10.1093/ofid/ofz360.1582
By:
- Frei, Michael;
- Aitken, Samuel L;
- Jain, Nitin;
- Thompson, Philip;
- Wierda, William G;
- Kontoyiannis, Dimitrios P;
- DiPippo, Adam
Publication type:
Article
2211. Impact of Early Fiberoptic Bronchoscopy on Microbiological Diagnostic Rate and Clinical Outcomes of Pneumonia in Acute Leukemia Patients.
Published in:
Open Forum Infectious Diseases, 2019, v. 6, p. S753, doi. 10.1093/ofid/ofz360.1889
By:
- Sakurai, Aki;
- Bala-Hampton, Justin E;
- Mulanovich, Victor E;
- Wierda, William G;
- Cortes, Jorge E;
- Adachi, Javier
Publication type:
Article
The TKI Era in Chronic Leukemias.
Published in:
Pharmaceutics, 2021, v. 13, n. 12, p. 2201, doi. 10.3390/pharmaceutics13122201
By:
- De Novellis, Danilo;
- Cacace, Fabiana;
- Caprioli, Valeria;
- Wierda, William G.;
- Mahadeo, Kris M.;
- Tambaro, Francesco Paolo
Publication type:
Article
Clinical and molecular characteristics and treatment patterns of adolescent and young adult patients with chronic lymphocytic leukaemia.
Published in:
British Journal of Haematology, 2021, v. 194, n. 1, p. 61, doi. 10.1111/bjh.17498
By:
- Cherng, Hua‐Jay J.;
- Jammal, Nadya;
- Paul, Shilpa;
- Wang, Xuemei;
- Sasaki, Koji;
- Thompson, Philip;
- Burger, Jan;
- Ferrajoli, Alessandra;
- Estrov, Zeev;
- O'Brien, Susan;
- Keating, Michael;
- Wierda, William G.;
- Jain, Nitin
Publication type:
Article
The landscape of genetic mutations in patients with chronic lymphocytic leukaemia and complex karyotype.
Published in:
British Journal of Haematology, 2019, v. 187, n. 1, p. e1, doi. 10.1111/bjh.16117
By:
- Strati, Paolo;
- Wang, Feng;
- Tambaro, Francesco P.;
- Thompson, Philip A.;
- Burger, Jan A.;
- Jain, Nitin;
- Ferrajoli, Alessandra;
- Bose, Prithviraj;
- Estrov, Zeev;
- Keating, Michael J.;
- Futreal, Andrew;
- Takahashi, Koichi;
- Wierda, William G.
Publication type:
Article
Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single‐agent ibrutinib in patients with chronic lymphocytic leukaemia.
Published in:
British Journal of Haematology, 2019, v. 186, n. 1, p. 184, doi. 10.1111/bjh.15791
By:
- Wierda, William G.;
- Byrd, John C.;
- O'Brien, Susan;
- Coutre, Steven;
- Barr, Paul M.;
- Furman, Richard R.;
- Kipps, Thomas J.;
- Burger, Jan A.;
- Stevens, Don A.;
- Sharman, Jeff;
- Ghia, Paolo;
- Flinn, Ian W.;
- Zhou, Cathy;
- Ninomoto, Joi;
- James, Danelle F.;
- Tam, Constantine S.
Publication type:
Article
Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B‐cell receptor pathway inhibitor.
Published in:
British Journal of Haematology, 2019, v. 185, n. 5, p. 961, doi. 10.1111/bjh.15666
By:
- Wierda, William G.;
- Byrd, John C.;
- Davids, Matthew S.;
- Furman, Richard R.;
- Cheson, Bruce D.;
- Barr, Paul M.;
- Eradat, Herbert;
- Heffner, Leonard;
- Zhou, Lang;
- Verdugo, Maria;
- Potluri, Jalaja;
- Choi, Michael
Publication type:
Article
Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials.
Published in:
British Journal of Haematology, 2018, v. 182, n. 4, p. 504, doi. 10.1111/bjh.15421
By:
- Jones, Jeffrey;
- Mato, Anthony;
- Coutre, Steven;
- Byrd, John C.;
- Furman, Richard R.;
- Hillmen, Peter;
- Osterborg, Anders;
- Tam, Constantine;
- Stilgenbauer, Stephan;
- Wierda, William G.;
- Heerema, Nyla A.;
- Eckert, Karl;
- Clow, Fong;
- Zhou, Cathy;
- Chu, Alvina D.;
- James, Danelle F.;
- O'Brien, Susan M.
Publication type:
Article
A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B‐cell acute lymphoblastic leukaemia.
Published in:
British Journal of Haematology, 2018, v. 182, n. 3, p. 442, doi. 10.1111/bjh.14806
By:
- Short, Nicholas J.;
- Kantarjian, Hagop;
- Jabbour, Elias;
- Cortes, Jorge E.;
- Thomas, Deborah A.;
- Rytting, Michael E.;
- Daver, Naval;
- Alvarado, Yesid;
- Konopleva, Marina;
- Kebriaei, Partow;
- Wierda, William G.;
- DiNardo, Courtney D.;
- Bivins, Carol;
- McCue, Deborah;
- Richie, Mary A.;
- Ravandi, Farhad
Publication type:
Article
Dynamic changes in CCL3 and CCL4 plasma concentrations in patients with chronic lymphocytic leukaemia managed with observation.
Published in:
British Journal of Haematology, 2018, v. 180, n. 4, p. 597, doi. 10.1111/bjh.14398
By:
- Sivina, Mariela;
- Werner, Lillian;
- Rassenti, Laura;
- Ferrajoli, Alessandra;
- Wierda, William G.;
- Keating, Michael J.;
- O'Brien, Susan;
- Neuberg, Donna;
- Kipps, Thomas;
- Burger, Jan A.
Publication type:
Article
The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab.
Published in:
British Journal of Haematology, 2018, v. 180, n. 1, p. 33, doi. 10.1111/bjh.15018
By:
- Jain, Preetesh;
- Nogueras González, Graciela M.;
- Kanagal‐Shamanna, Rashmi;
- Rozovski, Uri;
- Sarwari, Nawid;
- Tam, Constantine;
- Wierda, William G.;
- Thompson, Philip A.;
- Jain, Nitin;
- Luthra, Rajyalakshmi;
- Quesada, Andres;
- Sanchez‐Petitto, Gabriela;
- Ferrajoli, Alessandra;
- Burger, Jan;
- Kantarjian, Hagop;
- Cortes, Jorge;
- O'Brien, Susan;
- Keating, Michael J.;
- Estrov, Zeev
Publication type:
Article
Chlorinated adenosine analogue induces AMPK and autophagy in chronic lymphocytic leukaemia cells during therapy.
Published in:
British Journal of Haematology, 2017, v. 179, n. 2, p. 266, doi. 10.1111/bjh.14859
By:
- Stellrecht, Christine M.;
- Chen, Lisa S.;
- Ayres, Mary L.;
- Dennison, Jennifer B.;
- Shentu, Shujun;
- Chen, Yuling;
- Keating, Michael J.;
- Wierda, William G.;
- Gandhi, Varsha
Publication type:
Article
Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival.
Published in:
British Journal of Haematology, 2017, v. 177, n. 4, p. 567, doi. 10.1111/bjh.14596
By:
- Thompson, Philip A.;
- Stingo, Francesco;
- Keating, Michael J.;
- Wierda, William G.;
- O'Brien, Susan M.;
- Estrov, Zeev;
- Ledesma, Celina;
- Rezvani, Katayoun;
- Qazilbash, Muzaffar;
- Shah, Nina;
- Parmar, Simrit;
- Popat, Uday;
- Anderlini, Paolo;
- Yago, Nieto;
- Ciurea, Stefan O.;
- Kebriaei, Partow;
- Champlin, Richard;
- Shpall, Elizabeth J.;
- Hosing, Chitra M.
Publication type:
Article
The addition of CD20 monoclonal antibodies to lenalidomide improves response rates and survival in relapsed/refractory patients with chronic lymphocytic leukaemia relative to lenalidomide monotherapy - the MD Anderson Cancer Center experience.
Published in:
British Journal of Haematology, 2015, v. 171, n. 2, p. 281, doi. 10.1111/bjh.13377
By:
- Thompson, Philip A.;
- Rozovski, Uri;
- Keating, Michael J.;
- Stingo, Francesco;
- Smith, Susan C.;
- Wierda, William G.;
- Falchi, Lorenzo;
- O'Brien, Susan M.;
- Estrov, Zeev;
- Burger, Jan A.;
- Ferrajoli, Alessandra
Publication type:
Article
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients.
Published in:
British Journal of Haematology, 2015, v. 170, n. 1, p. 40, doi. 10.1111/bjh.13380
By:
- Österborg, Anders;
- Wierda, William G.;
- Mayer, Jiří;
- Hess, Georg;
- Hillmen, Peter;
- Schetelig, Johannes;
- Schuh, Anna;
- Smolej, Lukáš;
- Beck, Christian;
- Dreyfus, Brigitte;
- Hellman, Andrzej;
- Kozlowski, Piotr;
- Pfreundschuh, Michael;
- Rizzi, Rita;
- Spacek, Martin;
- Phillips, Jennifer L.;
- Gupta, Ira V.;
- Williams, Vanessa;
- Jewell, Roxanne C.;
- Nebot, Noelia
Publication type:
Article
Trisomy 12 is associated with an abbreviated redistribution lymphocytosis during treatment with the BTK inhibitor ibrutinib in patients with chronic lymphocytic leukaemia.
Published in:
British Journal of Haematology, 2015, v. 170, n. 1, p. 125, doi. 10.1111/bjh.13269
By:
- Thompson, Philip A.;
- Ferrajoli, Alessandra;
- O'Brien, Susan;
- Wierda, William G.;
- Keating, Michael J.;
- Burger, Jan A.
Publication type:
Article
Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells.
Published in:
Molecular Cancer, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-4598-12-50
By:
- Rozovski, Uri;
- Calin, George A.;
- Setoyama, Tetsuro;
- D'Abundo, Lucilla;
- Harris, David M.;
- Ping Li;
- Zhiming Liu;
- Grgurevic, Srdana;
- Ferrajoli, Alessandra;
- Faderl, Stefan;
- Burger, Jan A.;
- O'Brien, Susan;
- Wierda, William G.;
- Keating, Michael J.;
- Estrov, Zeev
Publication type:
Article
TP53‐altered chronic lymphocytic leukemia treated with firstline Bruton's tyrosine kinase inhibitor‐based therapy: A retrospective analysis.
Published in:
American Journal of Hematology, 2022, v. 97, n. 8, p. 1005, doi. 10.1002/ajh.26595
By:
- Cherng, Hua‐Jay J.;
- Khwaja, Raamis;
- Kanagal‐Shamanna, Rashmi;
- Tang, Guilin;
- Burger, Jan;
- Thompson, Philip;
- Ferrajoli, Alessandra;
- Estrov, Zeev;
- Sasaki, Koji;
- Sampath, Deepa;
- Wang, Xuemei;
- Kantarjian, Hagop;
- Keating, Michael;
- Wierda, William G.;
- Jain, Nitin
Publication type:
Article
Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome‐negative B‐cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab.
Published in:
American Journal of Hematology, 2022, v. 97, n. 6, p. E201, doi. 10.1002/ajh.26526
By:
- Short, Nicholas J.;
- Macaron, Walid;
- Konopleva, Marina;
- Ravandi, Farhad;
- Jain, Nitin;
- Issa, Ghayas C.;
- Kadia, Tapan;
- Sasaki, Koji;
- Kebriaei, Partow;
- Yilmaz, Musa;
- Thompson, Philip A.;
- Takahashi, Koichi;
- Abbas, Hussein A.;
- Wierda, William G.;
- Garris, Rebecca;
- Kantarjian, Hagop M.;
- Jabbour, Elias
Publication type:
Article
Non‐coding NOTCH1 mutations in chronic lymphocytic leukemia negatively impact prognosis.
Published in:
American Journal of Hematology, 2022, v. 97, n. 3, p. E100, doi. 10.1002/ajh.26457
By:
- Jelloul, Fatima Zahra;
- Yang, Richard K.;
- Wang, Peng;
- Garces, Sofia;
- Kanagal‐Shamanna, Rashmi;
- Ok, Chi Y.;
- Loghavi, Sanam;
- Routbort, Mark J.;
- Zuo, Zhuang;
- Yin, Cheng Cameron;
- Floyd, Kristen;
- Bassett, Roland L.;
- Wierda, William G.;
- Jain, Nitin;
- Thompson, Philip A.;
- Luthra, Rajyalakshmi;
- Medeiros, Leonard Jeffrey;
- Patel, Keyur P.
Publication type:
Article
The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomes.
Published in:
American Journal of Hematology, 2021, v. 96, n. 2, p. 241, doi. 10.1002/ajh.26047
By:
- Sasaki, Koji;
- Jabbour, Elias J.;
- Ravandi, Farhad;
- Konopleva, Marina;
- Borthakur, Gautam;
- Wierda, William G.;
- Daver, Naval;
- Takahashi, Koichi;
- Naqvi, Kiran;
- DiNardo, Courtney;
- Montalban‐Bravo, Guillermo;
- Kanagal‐Shamanna, Rashmi;
- Issa, Ghayas;
- Jain, Preetesh;
- Skinner, Jeffrey;
- Rios, Mary B.;
- Pierce, Sherry;
- Soltysiak, Kelly A.;
- Sato, Junya;
- Garcia‐Manero, Guillermo
Publication type:
Article
Targeting BCL2 in Chronic Lymphocytic Leukemia and Other Hematologic Malignancies.
Published in:
Drugs, 2019, v. 79, n. 12, p. 1287, doi. 10.1007/s40265-019-01163-4
By:
- Yalniz, Fevzi F.;
- Wierda, William G.
Publication type:
Article
Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations.
Published in:
PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0128151
By:
- Deniger, Drew C.;
- Yu, Jianqiang;
- Huls, M. Helen;
- Figliola, Matthew J.;
- Mi, Tiejuan;
- Maiti, Sourindra N.;
- 2ndWidhopf, George F.;
- Hurton, Lenka V.;
- Thokala, Radhika;
- Singh, Harjeet;
- Olivares, Simon;
- Champlin, Richard E.;
- Wierda, William G.;
- Kipps, Thomas J.;
- Cooper, Laurence J. N.
Publication type:
Article
The PI3-Kinase Delta Inhibitor Idelalisib (GS-1101) Targets Integrin-Mediated Adhesion of Chronic Lymphocytic Leukemia (CLL) Cell to Endothelial and Marrow Stromal Cells.
Published in:
PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0083830
By:
- Fiorcari, Stefania;
- Brown, Wells S.;
- McIntyre, Bradley W.;
- Estrov, Zeev;
- Maffei, Rossana;
- O’Brien, Susan;
- Sivina, Mariela;
- Hoellenriegel, Julia;
- Wierda, William G.;
- Keating, Michael J.;
- Ding, Wei;
- Kay, Neil E.;
- Lannutti, Brian J.;
- Marasca, Roberto;
- Burger, Jan A.
Publication type:
Article
Generation of Functional CLL-Specific Cord Blood CTL Using CD40-Ligated CLL APC.
Published in:
PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0051390
By:
- Decker, William K.;
- Nina Shah;
- Dongxia Xing;
- Lapushin, Ruth;
- Sufang Li;
- Robinson, Simon N.;
- Hong Yang;
- Parmar, Simrit;
- Halpert, Matthew M.;
- Keating, Michael J.;
- Gribben, John G.;
- Molldrem, Jeffrey J.;
- Shpall, Elizabeth J.;
- Wierda, William G.
Publication type:
Article
A Two-Gene Signature, SKI and SLAMF1, Predicts Time-to-Treatment in Previously Untreated Patients with Chronic Lymphocytic Leukemia.
Published in:
PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0028277
By:
- Schweighofer, Carmen D.;
- Coombes, Kevin R.;
- Barron, Lynn L.;
- Diao, Lixia;
- Newman, Rachel J.;
- Ferrajoli, Alessandra;
- O'Brien, Susan;
- Wierda, William G.;
- Luthra, Rajyalakshmi;
- Medeiros, L. Jeffrey;
- Keating, Michael J.;
- Abruzzo, Lynne V.
Publication type:
Article
Recent Updates in Monitoring and Sequencing Treatment in Chronic Lymphocytic Leukemia.
Published in:
Oncology (08909091), 2023, v. 37, n. 3, p. 150
By:
- Wierda, William G.
Publication type:
Article
Selection of a Nuclease-Resistant RNA Aptamer Targeting CD19.
Published in:
Cancers, 2021, v. 13, n. 20, p. 5220, doi. 10.3390/cancers13205220
By:
- Esposito, Carla L.;
- Van Roosbroeck, Katrien;
- Santamaria, Gianluca;
- Rotoli, Deborah;
- Sandomenico, Annamaria;
- Wierda, William G.;
- Ferrajoli, Alessandra;
- Ruvo, Menotti;
- Calin, George A.;
- de Franciscis, Vittorio;
- Catuogno, Silvia
Publication type:
Article
Does FCR Have the Potential to Cure a Subgroup of Patients With Chronic Lymphocytic Leukemia?
Published in:
Clinical Advances in Hematology & Oncology, 2019, v. 17, n. 4, p. 214
By:
- Wierda, William G.
Publication type:
Article
High serum thymidine kinase 1 level predicts poorer survival in patients with chronic lymphocytic leukemia.
Published in:
2010
By:
- Konoplev, Sergej N.;
- Fritsche, Herbert A.;
- O'Brien, Susan;
- Wierda, William G.;
- Keating, Michael J.;
- Gornet, Terrie G.;
- St Romain, Susan;
- Xuemei Wang;
- Inamdar, Kedar;
- Johnson, Malisha R.;
- Medeiros, L. Jeffrey;
- Bueso-Ramos, Carlos E.;
- Wang, Xuemei
Publication type:
journal article
Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic Leukemia.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.833714
By:
- Yi, Xue;
- Jain, Nitin;
- Iles, LaKesla R.;
- Ayres, Mary L.;
- Wierda, William G.;
- Gandhi, Varsha
Publication type:
Article
Monitoring and Managing BTK Inhibitor Treatment-Related Adverse Events in Clinical Practice.
Published in:
Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.720704
By:
- O'Brien, Susan M.;
- Brown, Jennifer R.;
- Byrd, John C.;
- Furman, Richard R.;
- Ghia, Paolo;
- Sharman, Jeff P.;
- Wierda, William G.
Publication type:
Article
Acalabrutinib: A Selective Bruton Tyrosine Kinase Inhibitor for the Treatment of B-Cell Malignancies.
Published in:
Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.668162
By:
- Abbas, Hussein A.;
- Wierda, William G.
Publication type:
Article
Phase I-II Clinical Trial of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Therapy in Aggressive Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 5, p. 568, doi. 10.1016/j.clml.2013.03.012
By:
- Tsimberidou, Apostolia M.;
- Wierda, William G.;
- Wen, Sijin;
- Plunkett, William;
- O'Brien, Susan;
- Kipps, Thomas J.;
- Jones, Jeffrey A.;
- Badoux, Xavier;
- Kantarjian, Hagop;
- Keating, Michael J.
Publication type:
Article
Chronic Lymphocytic Leukemia: New Concepts for Future Therapy.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 5, p. 369, doi. 10.3816/CLML.2010.n.070
By:
- Wierda, William G.;
- Chiorazzi, Nicholas;
- Dearden, Claire;
- Brown, Jennifer R.;
- Montserrat, Emili;
- Shpall, Elizabeth;
- Stilgenbauer, Stephan;
- Muneer, Sabeeha;
- Grever, Michael
Publication type:
Article
Role of CD20 Monoclonal Antibodies in Previously Untreated Chronic Lymphocytic Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, p. S27, doi. 10.3816/CLML.2010.s.004
By:
- Parikh, Sameer A.;
- Wierda, William G.
Publication type:
Article
Long-Term Results of Chemoimmunotherapy With Fludarabine, Cyclophosphamide, and Rituximab for Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 3, p. E35, doi. 10.3816/CLML.2010.n.044
By:
- Badoux, Xavier;
- Keating, Michael J.;
- Ferrajoli, Alessandra;
- Lerner, Susan;
- Wang, Xuemei;
- O'Brien, Susan;
- Wierda, William G.
Publication type:
Article
Ofatumumab Combined With Fludarabine and Cyclophosphamide (O-FC) Shows High Activity in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Results From a Randomized, Multicenter, International, Two-Dose, Parallel-Group Phase II Trial.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 3, p. E33, doi. 10.3816/CLML.2010.n.043
By:
- Wierda, William G.;
- Kipps, Thomas J.;
- Dürig, Jan;
- Griskevicius, Laimonas;
- Stilgenbauer, Stephan;
- Mayer, Jiri;
- Smolej, Lukas;
- Hess, Georg;
- Griniute, Rasa;
- Hernandez-Ilizaliturri, Francisco J.;
- Padmanabhan, Swaminathan;
- Gorczyca, Michele;
- Gupta, Ira;
- Nielsen, Tina G.;
- Russell, Charlotte A.
Publication type:
Article
Pilot experience with continuous infusion alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia.
Published in:
European Journal of Haematology, 2008, v. 80, n. 4, p. 296, doi. 10.1111/j.1600-0609.2007.01023.x
By:
- Ferrajoli, Alessandra;
- Wierda, William G.;
- LaPushin, Ruth;
- O'Brien, Susan M.;
- Faderl, Stefan;
- Browning, Mary L.;
- Keating, Michael J.
Publication type:
Article
Genetics and molecular biology of chronic lymphocytic leukemia.
Published in:
2005
By:
- Carney, Dennis;
- Wierda, William;
- Carney, Dennis A;
- Wierda, William G
Publication type:
journal article
Multiple-dose granulocyte-macrophage-colony-stimulating factor plus 23-valent polysaccharide pneumococcal vaccine in patients with chronic lymphocytic leukemia: a prospective, randomized trial of safety and immunogenicity.
Published in:
2008
By:
- Safdar, Amar;
- Rodriguez, Gilhen H.;
- Rueda, Adriana M.;
- Wierda, William G.;
- Ferrajoli, Alessandra;
- Musher, Daniel M.;
- O'Brien, Susan;
- Koller, Charles A.;
- Bodey, Gerald P.;
- Keating, Michael J.
Publication type:
journal article
Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone.
Published in:
2006
By:
- Tsimberidou, Apostolia M;
- Catovsky, Daniel;
- Schlette, Ellen;
- O'Brien, Susan;
- Wierda, William G;
- Kantarjian, Hagop;
- Garcia-Manero, Guillermo;
- Wen, Sijin;
- Do, Kim-Anh;
- Lerner, Susan;
- Keating, Michael J
Publication type:
journal article
Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone.
Published in:
Cancer (0008543X), 2006, v. 107, n. 1, p. 125
By:
- Apostolia M. Tsimberidou;
- Daniel Catovsky;
- Ellen Schlette;
- Susan O'Brien;
- William G. Wierda;
- Hagop Kantarjian;
- Guillermo Garcia‐Manero;
- Sijin Wen;
- Kim‐Anh Do;
- Susan Lerner;
- Michael J. Keating
Publication type:
Article
Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia.
Published in:
Cancer (0008543X), 2006, v. 106, n. 7, p. 1569
By:
- Deborah A. Thomas;
- Stefan Faderl;
- Susan O'Brien;
- Carlos Bueso‐Ramos;
- Jorge Cortes;
- Guillermo Garcia‐Manero;
- Francis J. Giles;
- Srdan Verstovsek;
- William G. Wierda;
- Sherry A. Pierce;
- Jianqin Shan;
- Mark Brandt;
- Fredrick B. Hagemeister;
- Michael J. Keating;
- Fernando Cabanillas;
- Hagop Kantarjian
Publication type:
Article
Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia.
Published in:
Cancer (0008543X), 2004, v. 100, n. 12, p. 2583
By:
- Apostolia M. Tsimberidou;
- Michael J. Keating;
- Francis J. Giles;
- William G. Wierda;
- Alessandra Ferrajoli;
- Susan Lerner;
- Miloslav Beran;
- Michael Andreeff;
- Hagop M. Kantarjian;
- Susan O'Brien
Publication type:
Article
Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in Richter syndrome.
Published in:
2004
By:
- Tsimberidou, Apostolia-Maria;
- Murray, James L;
- O'Brien, Susan;
- Wierda, William G;
- Keating, Michael J
Publication type:
journal article
Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in Richter syndrome.
Published in:
Cancer (0008543X), 2004, v. 100, n. 10, p. 2195
By:
- Apostolia-Maria Tsimberidou;
- James L. Murray;
- Susan O'Brien;
- William G. Wierda;
- Michael J. Keating
Publication type:
Article
Phase I and pharmacokinetic study of a low-clearance, unilamellar liposomal formulation of lurtotecan, a topoisomerase 1 inhibitor, in patients with advanced leukemia.
Published in:
Cancer (0008543X), 2004, v. 100, n. 7, p. 1449
By:
- Francis J. Giles;
- Martin S. Tallman;
- Guillermo Garcia-Manero;
- Jorge E. Cortes;
- Deborah A. Thomas;
- William G. Wierda;
- Srdan Verstovsek;
- Marta Hamilton;
- Emma Barrett;
- Maher Albitar;
- Hagop M. Kantarjian
Publication type:
Article
Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein (Dr. Armand Keating was a guest editor for this article.).
Published in:
Cancer (0008543X), 2004, v. 100, n. 7, p. 1459
By:
- Barbara Scappini;
- Simona Gatto;
- Francesco Onida;
- Clara Ricci;
- Vladimir Divoky;
- William G. Wierda;
- Michael Andreeff;
- Li Dong;
- Kimberly Hayes;
- Srdan Verstovsek;
- Hagop M. Kantarjian;
- Miloslav Beran
Publication type:
Article

Found: 102